menu
    • menu

    Company profile for Nexus Pharmaceuticals

    NEW Drugs in Dev: 9
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Nexus Pharmaceuticals we are inspired by a single goal: to develop new and safe generics that prevent and treat the world's most serious diseases.Nexus Pharmaceuticals is a US-based, woman-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Ne...
    At Nexus Pharmaceuticals we are inspired by a single goal: to develop new and safe generics that prevent and treat the world's most serious diseases.Nexus Pharmaceuticals is a US-based, woman-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nexus PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Knightsbridge Parkway, Lincolnshire, IL 60069
    Telephone
    Telephone
    (847) 996-3790
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nexuspharma.net/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nexus-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Terpene Belt Farms Wins UCLA-Led State-Funded Cannabis Grant
    Terpene Belt Farms Wins UCLA-Led State-Funded Cannabis Grant

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nexus-agriscience-subsidiary-terpene-belt-farms-selected-for-ucla-led-state-funded-cannabis-research-grant-302676246.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    Nexus Pharmaceuticals Launches Tacrolimus Injection
    Nexus Pharmaceuticals Launches Tacrolimus Injection

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251201214335/en/Nexus-Pharmaceuticals-Launches-Tacrolimus-Injection

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    Nexus`s Generics Minocycline Receives Tentative Approval in US
    Nexus`s Generics Minocycline Receives Tentative Approval in US

    12 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214934

    FDA
    12 Jun 2025
    Share Share
    Nexus Wins Patent Litigation for Injectable Cyclophosphamide
    Nexus Wins Patent Litigation for Injectable Cyclophosphamide

    28 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250528703755/en/Nexus-Wins-Patent-Litigation-for-Injectable-Cyclophosphamide-Paving-Way-for-Generic

    BUSINESSWIRE
    28 May 2025
    Share Share
    Nexus Pharmaceuticals Launches Methylene Blue Injection
    Nexus Pharmaceuticals Launches Methylene Blue Injection

    22 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522266031/en/Nexus-Pharmaceuticals-Launches-Methylene-Blue-Injection

    BUSINESSWIRE
    22 May 2025
    Share Share
    Nexus Pharmaceuticals Launches Baclofen Injection Refill Kit
    Nexus Pharmaceuticals Launches Baclofen Injection Refill Kit

    11 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250410021009/en/Nexus-Pharmaceuticals-Launches-Baclofen-Injection-Refill-Kit

    BUSINESSWIRE
    11 Apr 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search